Ori Gutwerg
Overview
Ori Gutwerg received $2M in total compensation, including $355K in salary, at ANI Pharmaceuticals in 2021.
Source: SEC filing on March 25, 2022.
Related executives
We found 11 more executives who work or worked at ANI Pharmaceuticals.
Nikhil Lalwani
ANI Pharmaceuticals
Chief Executive Officer
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
Christopher Mutz
ANI Pharmaceuticals
Head of Rare Disease
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
Arthur Przybyl
ANI Pharmaceuticals
Chief Executive Officer
Charlotte Arnold
ANI Pharmaceuticals